FDA approvals drop 8% in 2025, with fewer blockbusters; Brinsupri, Rhapsido make it to first-in-class list

Data Compilation
#PharmaFlow

Pipeline Prospector February 2026 highlights: Gilead buys Arcellx for US$ 7.8 bn; FDA okays Vanda’s psychotic pill

Stock Recap
#PipelineProspector

Budesonide

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

88 API Suppliers, 25 USDMF, 27 CEP/COS, 5 JDMF, 8 EU WC, 17 KDMF, 35 NDC API, 45 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

240 Drugs in Development

240 Drugs in Development

INTERMEDIATES

7 Intermediate Suppliers

7 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

1369 FDF Dossiers, 54 FDA Orange Book, 1118 Europe, 23 Canada, 79 Australia, 39 South Africa, 56 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET, EXTENDED RELEASE;ORAL - 9MG, AEROSOL, FOAM;RECTAL - 2MG/ACTUATION, SPRAY, METERED;NASAL - 0.032MG/SPRAY, SUSPENSION;INHALATION - 0.25MG/2ML, SUSPENSION;INHALATION - 0.5MG/2ML, SUSPENSION;INHALATION - 1MG/2ML, CAPSULE, DELAYED RELEASE;ORAL - 6MG, CAPSULE, DELAYED RELEASE;ORAL - 9MG, CAPSULE, DELAYED RELEASE;ORAL - 3MG, AEROSOL, METERED;INHALATION - 0.08MG/INH;0.0045MG/INH, AEROSOL, METERED;INHALATION - 0.16MG/INH;0.0045MG/INH

RELATED EXCIPIENT COMPANIES

4 Evonik, 1 Rochem International Inc, 5 SPI Pharma, 3 Gangwal Healthcare, 6 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 9 Kirsch Pharma, 4 ACG Worldwide, 11 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 23 BASF, 1 CD Formulation, 1 Clariant, 14 Corel Pharma Chem, 4 DFE Pharma, 3 Doshion Polyscience, 1 Esteem Industries, 2 Finar, 10 Gangwal Chemicals, 1 Gloria Interchem, 8 Ideal Cures, 2 Ingredion Pharma Solutions, 20 Kerry, 2 Keval Exports, 5 Kima Chemical, 6 Lonza Capsugel, 16 Microlex e.U, 1 Nanjing Bold Chemical, 1 Neelkanth MineChem, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 1 Novo Excipients, 1 Pharmatrans-Sanaq, 5 Pluviaendo, 2 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 18 Roquette, 14 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 9 Sigachi Industries, 2 Silverline Chemicals, 4 The Dow Chemical Company, 2 Valens Pharmachem, 2 Vasa Pharmachem, 2 Vertellus

EXCIPIENTS BY APPLICATIONS

62 Coating Systems & Additives, 49 Fillers, Diluents & Binders, 35 Controlled & Modified Release, 34 Thickeners and Stabilizers, 25 Solubilizers, 23 Granulation, 23 Direct Compression, 20 Parenteral, 20 Film Formers & Plasticizers, 20 Taste Masking, 19 Topical, 18 Lubricants & Glidants, 11 Co-Processed Excipients, 10 Emulsifying Agents, 9 Empty Capsules, 9 Disintegrants & Superdisintegrants, 8 Chewable & Orodispersible Aids, 5 Surfactant & Foaming Agents, 5 API Stability Enhancers, 5 Rheology Modifiers, 4 Vegetarian Capsules, 2 Coloring Agents

DIGITAL CONTENT

2 Data Compilation #PharmaFlow, 1 Stock Recap #PipelineProspector, 147 News #PharmaBuzz

GLOBAL SALES INFORMATION

34 US Medicaid Prescriptions, 91 Regulatory FDF Prices, 51 Annual Reports

MARKET PLACE

20 APIs, 17 FDF Dossiers, 1 EXCIPIENTS

PATENTS & EXCLUSIVITIES

39 US Patents, 4 US Exclusivities, 16 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 21 USP, 15 Others

ANALYTICAL

3 BioAnalytical Methods

3 BioAnalytical Methods

$ Xls

Filters

CAPSULE, DELAYED RELEASE;ORAL - 9MG

CAPSULE, DELAYED RELEASE;ORAL - 6MG

CAPSULE, DELAYED RELEASE;ORAL - 3MG

SPRAY, METERED;NASAL - 0.032MG/SPRAY

AEROSOL, FOAM;RECTAL - 2MG/ACTUATION

AEROSOL, METERED;INHALATION - 0.08MG/INH;0.0045MG/INH

AEROSOL, METERED;INHALATION - 0.16MG/INH;0.0045MG/INH

TABLET, EXTENDED RELEASE;ORAL - 9MG

SUSPENSION;INHALATION - 0.25MG/2ML

SUSPENSION;INHALATION - 0.5MG/2ML

SUSPENSION;INHALATION - 1MG/2ML

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

Budesonide

Budesonide

ACCESS ALL DATA

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

88 API Suppliers

25 USDMF

27 CEP/COS

5 JDMF

8 EU WC

17 KDMF

35 NDC API

45 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

240 Drugs in Development

INTERMEDIATES

7 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

1369 FDF Dossiers

54 FDA Orange Book

1118 Europe

23 Canada

79 Australia

39 South Africa

56 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET, EXTENDED RELEASE;ORAL - 9MG

AEROSOL, FOAM;RECTAL - 2MG/ACTUATION

SPRAY, METERED;NASAL - 0.032MG/SPRAY

SUSPENSION;INHALATION - 0.25MG/2ML

SUSPENSION;INHALATION - 0.5MG/2ML

SUSPENSION;INHALATION - 1MG/2ML

CAPSULE, DELAYED RELEASE;ORAL - 6MG

CAPSULE, DELAYED RELEASE;ORAL - 9MG

CAPSULE, DELAYED RELEASE;ORAL - 3MG

AEROSOL, METERED;INHALATION - 0.08MG/INH;0.0045MG/INH

AEROSOL, METERED;INHALATION - 0.16MG/INH;0.0045MG/INH

RELATED EXCIPIENT COMPANIES

4 Evonik

1 Rochem International Inc

5 SPI Pharma

3 Gangwal Healthcare

6 Nanjing Well Pharmaceutical

1 Pfanstiehl

9 Kirsch Pharma

4 ACG Worldwide

11 Actylis

1 Aeon Procare

1 Alcedo Pharmachem

5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

1 Ashland

23 BASF

1 CD Formulation

1 Clariant

14 Corel Pharma Chem

4 DFE Pharma

3 Doshion Polyscience

1 Esteem Industries

2 Finar

10 Gangwal Chemicals

1 Gloria Interchem

8 Ideal Cures

2 Ingredion Pharma Solutions

20 Kerry

2 Keval Exports

5 Kima Chemical

6 Lonza Capsugel

16 Microlex e.U

1 Nanjing Bold Chemical

1 Neelkanth MineChem

2 Nitika Pharmaceutical Specialities

2 Nomisma Healthcare

1 Novo Excipients

1 Pharmatrans-Sanaq

5 Pluviaendo

2 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

2 Qualicaps